Role of oxidatively modified LDL in atherosclerosis
- PMID: 2227530
- DOI: 10.1016/0891-5849(90)90119-4
Role of oxidatively modified LDL in atherosclerosis
Abstract
Oxidative modification of LDL is accompanied by a number of compositional and structural changes, including increased electrophoretic mobility, increased density, fragmentation of apolipoprotein B, hydrolysis of phosphatidylcholine, derivatization of lysine amino groups, and generation of fluorescent adducts due to covalent binding of lipid oxidation products to apo B. In addition, oxidation of LDL has been shown to result in numerous changes in its biologic properties that could have pathogenetic importance, including accelerated uptake in macrophages, cytotoxicity, and chemotactic activity for monocytes. The present article summarizes very recent developments related to the mechanism of oxidation of LDL by cells, receptor-mediated uptake of oxidized LDL in macrophages, the mechanism of phosphatidylcholine hydrolysis during LDL oxidation, and other biologic actions of oxidized LDL including cytotoxicity, altered eicosanoid metabolism, and effects on the secretion of growth factors and chemotactic factors. In addition, this review will examine the evidence for the presence of oxidized LDL in vivo and the evidence that oxidized LDL plays a pathogenetic role in atherosclerosis.
Similar articles
-
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.J Clin Invest. 1989 Oct;84(4):1086-95. doi: 10.1172/JCI114271. J Clin Invest. 1989. PMID: 2794046 Free PMC article.
-
Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications.Chem Phys Lipids. 1987 Nov-Dec;45(2-4):315-36. doi: 10.1016/0009-3084(87)90070-3. Chem Phys Lipids. 1987. PMID: 3319231 Review.
-
Oxidation of human low density lipoprotein results in derivatization of lysine residues of apolipoprotein B by lipid peroxide decomposition products.J Biol Chem. 1987 Mar 15;262(8):3603-8. J Biol Chem. 1987. PMID: 3102491
-
Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis.Biochemistry. 1994 Oct 18;33(41):12487-94. doi: 10.1021/bi00207a016. Biochemistry. 1994. PMID: 7918471
-
Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants.Eur J Clin Chem Clin Biochem. 1996 Aug;34(8):599-608. Eur J Clin Chem Clin Biochem. 1996. PMID: 8877334 Review.
Cited by
-
Anti-inflammatory effects of Z-ligustilide nanoemulsion.Inflammation. 2013 Apr;36(2):294-9. doi: 10.1007/s10753-012-9546-2. Inflammation. 2013. PMID: 23007925
-
Influence of oxidized low density lipoprotein on the proliferation of human artery smooth muscle cells in vitro.J Huazhong Univ Sci Technolog Med Sci. 2007 Feb;27(1):20-3. doi: 10.1007/s11596-007-0106-1. J Huazhong Univ Sci Technolog Med Sci. 2007. Retraction in: J Huazhong Univ Sci Technolog Med Sci. 2008 Apr;28(2):234. doi: 10.1007/s11596-008-0231-5. PMID: 17393100 Retracted.
-
Acute myocardial infarction is associated with increased susceptibility of serum lipids to copper-induced peroxidation in vitro.Clin Cardiol. 2002 Feb;25(2):63-8. doi: 10.1002/clc.4950250205. Clin Cardiol. 2002. PMID: 11841152 Free PMC article.
-
Detection of HOCl-mediated protein oxidation products in the extracellular matrix of human atherosclerotic plaques.Biochem J. 2003 Mar 1;370(Pt 2):729-35. doi: 10.1042/BJ20021710. Biochem J. 2003. PMID: 12456264 Free PMC article.
-
Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro.J Clin Invest. 1999 Jun;103(11):1547-60. doi: 10.1172/JCI5549. J Clin Invest. 1999. PMID: 10359564 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical